A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Methamphetamine Addiction

In brief

The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants will attend research visits twice per week, and will receive individual counseling sessions once per week for all 9 weeks. 50% of the participants will receive the active medication while the other 50% will receive the placebo (sugar pill). Neither the participant or the study team will know if the participant is receiving the placebo or active drug.

Key facts

Study ID

NCT00630682

Run by

California Pacific Medical Center Research Institute

People needed

60

Starts

2006-09-01

Expected to finish

2011-08-01

Last updated by the study team

2013-06-03

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-50 yrs. old

You may not qualify if…

• pregnant or lactating females
• Contact site for additional information

Where it is running

• CPMC-St. Luke's Campus-Addiction Pharmacology Research Laboratory — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.